M.D.
ActiveSummary
The annual accounts of M.D. for financial year 2025 show a net loss of 82% of the equity at the start of that year. The 2025 annual accounts show equity of €8,478 and a net result of -€9,625. Equity is shrinking by about 8.5% per year across the filed financial years. Its solvency ranks better than 31% of 22,554 sector peers (NACE 47, financial year 2025). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.4% (low).
History
Acts, filings and financial milestones
22-01
Gazette deed
Appointment: CHAUDHRY Mushahid (director)Power of attorney · Registered office clause · Capital conversion12 facts ▸
- Power of attorney, Luc MORTELMANS
- Other provision, “bestuurder” (deed in Dutch)
- Director appointment, CHAUDHRY Mushahid (director)
- Registered office clause, “2100 Antwerpen-Deurne,Gallifortlei 124, ZEVENDE BESLUIT:VASTSTELLING VAN HET ADRES VAN DE ZETEL BUITEN DE STATUTEN” (deed in Dutch)
- General meeting, 13-12-2023
- Other provision, “aanpassing statuten aan WVV met behoud rechtsvorm, aanpassen aan (nieuw) Wetboek van vennootschappen en verenigingen” (deed in Dutch)
- Capital conversion, EUR, “van rechtswege omgezet” (deed in Dutch)
- Reserve release, “opheffen statutair onbeschikbare eigen vermogensrekening en beschikbaar maken voor uitkering, eigen vermogensrekening niet-opgevraagde inbrengen” (deed in Dutch)
- Other provision, “voorlezing en toelichting uitkeringstests door notaris, algemene vergadering” (deed in Dutch)
- Registered office clause, “beperkt tot aanduiding Gewest, adres zetel niet meer in statuten” (deed in Dutch)
- Amendment of the articles
- Capital
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.